Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Oil A formulation with Baricitinib shows promise for treating alopecia areata by promoting hair growth.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Natural products show promise for new hair loss treatments.

Bee venom, fig, and geranium oil can effectively treat skin conditions and are safer alternatives to some conventional drugs.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Stem cell technology may improve hair loss treatments by providing more effective and personalized options.